Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo

Cancer Research

Volumn 64, Issue 20, 2004, Pages 7210-7215

  Johnsen, John I ^a   Lindskog, Magnus ^a   Ponthan, Frida ^a   Pettersen, Ingvild ^b   Elfman, Lotta ^a   Orrego, Abiel ^a   Sveinbjörnsson, Baldur ^b   Kogner, Per ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF TROMSØ   (Norway)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CASPASE; CELECOXIB; CHOLINE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; LIPOXYGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; POLYUNSATURATED FATTY ACID;

ADRENAL MEDULLA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN MITOCHONDRION; CANCER INHIBITION; CELL DEATH; CHILD; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFANT; MALE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; TUMOR CELL LINE; XENOGRAFT;

ADRENAL GLAND NEOPLASMS; ADRENAL MEDULLA; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DICLOFENAC; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; ISOENZYMES; MALE; MEMBRANE PROTEINS; NEUROBLASTOMA; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RATS; RATS, NUDE; SULFONAMIDES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 5644294350     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1795     Document Type: Article

References (20)

1. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003;3:203-16.
2. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000;69:145-82.
3. Gasparini G, Longo R, Sarmiento R, Morabito A. Inhibitors of cyclooxygenase 2: a new class of anticancer agents? Lancet Oncol 2003;10:605-15.
4. Ponthan F, Johnsen JI, Klevenvall L, Castro J, Kogner P. The synthetic retinoid RO 13-6307 induces neuroblastoma differentiation in vitro and inhibits neuroblastoma tumour growth in vivo. Int J Cancer 2003;104:418-24.
5. Salmenkivi K, Haglund C, Ristimaki A, Arola J, Heikkila P. Increased expression of cyclooxygenase-2 in malignant pheochromocytomas. J Clin Endocrinol Metab 2001;86:5615-9.
6. Reynolds LM, Dalton CF, Gavin P. Phospholipid fatty acids and neurotoxicity in human neuroblastoma SH-SY5Y cells. Neurosci Lett 2001;309:93-196.
7. Hakumäki JM, Brindle KM. Visualizing apoptosis using nuclear magnetic resonance. Trends Pharmacol Sci 2003;24:146-9.
8. Brash AR. Arachidonic acid as a bioactive molecule. J Clin Investig 2001;107:1339-45.
9. 1H MRS). Br J Cancer 2003;8:478-85.
10. Scorrano L, Penzo D, Petronilli V, Pagano F, Bernardi P. Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha apoptotic signaling. J Biol Chem 2001;276:12035-40.
11. Togna GI, Togna AR, Franconi M, Caprino L. Cisplatin triggers platelet activation. Thromb Res 2000;99:503-9.
12. Levine L. Does the release of arachidonic acid from cells play a role in cancer chemoprevention? FASEB J 2003;7:800-2.
13. Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science (Wash DC) 1996;274:1855-9.
14. Perry DK. The role of de novo ceramide synthesis in chemotherapy-induced apoptosis. Ann N Y Acad Sci 2000;905:91-6.
15. Yamamoto Y, Jin MJ, Lin KM, Gaynor RB. Sulindac inhibits activation of the NF-kappaB pathway. J Biol Chem 1999;274:27307-14.
16. Gupta RA, Tan J, Krause WF, et al. Prostacyclin-mediated activation of PPARγ in coiorectal cancer. Proc Natl Acad Sci USA 2000;97:13275-80.
17. Han S, Wada RK, Sidell N. Differentiation of human neuroblastoma by phenylacetate is mediated by peroxisome proliferator-activated receptor gamma. Cancer Res 2001;61:3998-4002.
18. Ackerstaff E, Pflug BR, Nelson JB, Bhujwalla ZM. Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res 2001;61:3599-603.
19. Lindskog M, Spenger C, Jarvet J, Graslund A, Kogner P. Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma. J Natl Cancer Inst (Bethesda) 2004;96:1457-66.
20. Natarajan K, Mori N, Artemov D, Bhujwalla ZM. Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression. Neoplasia 2002;4:409-16.